|
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITINGN/ASponsored by Dana-Farber Cancer Institute
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2022-01-18
Est. completion2025-12-31
Eligibility
Age70 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04674267
Summary
The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.
Eligibility
Age: 70 Years+Healthy volunteers accepted
Inclusion Criteria: * Patients who are age 70+ at time of initial consult at DF/BWCC * Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors. * Continuing care at DF/BWCC beyond initial consult visit * English and Spanish-speaking Exclusion Criteria: * Patients less than age 70 at time of initial consultation appointment with DF/BWCC. * Patients who are not continuing care at DF/BWCC beyond first consult visit. * Not proficient in English or Spanish * Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team. * Participants with psychiatric illness/social situations that would limit compliance with study requirements.
Conditions7
CancerColon CancerEsophageal CancerGastric CancerGastrointestinal CancerPancreatic CancerRectal Cancer
Locations1 site
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2022-01-18
Est. completion2025-12-31
Eligibility
Age70 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04674267